Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates on February 27, 2025

About this update from Iovance Biotherapeutics, Inc.

[{"type":"image","alt":"Iovance Biotherapeutics, Inc.","displaySize":"","headline":null,"caption":"Iovance Biotherapeutics, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":98,"url":"https://media.zenfs.com/en/globenewswire.com/fb47f4fbc477e50ab2663b1d46d1f520"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/.v3WcxvLExw0gdNQeyFn2w--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEzNztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/fb47f4fbc477e50ab2663b1d46d1f520","width":300,"height":98}},"lazy":false},{"type":"text","content":"SAN CARLOS, Calif., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, will report its fourth quarter and full year 2024 financial results and corporate updates on Thursday, February 27, 2025.","length":384,"tagName":"p"},{"type":"text","content":"Fourth Quarter and Full Year 2024 Audio WebcastManagement will host a live audio webcast to discuss these results and provide a corporate update on February 27, 2025 at 4:30 p.m. EST. To listen to the live or archived audio webcast, please register at https://edge.media-server.com/mmc/p/hw2g9axf/.","length":299,"tagName":"p"},{"type":"text","content":"Upcoming Conference Participation","length":33,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"TD Cowen’s 45th Annual Health Care ConferenceFireside Chat: March 3, 2025 at 9:10 a.m. ETBoston, MA","length":121,"tagName":"p"}]},{"val":[{"type":"text","content":"Barclays 27th Annual Global Healthcare ConferenceFireside Chat: March 13, 2025 at 9:30 a.m. ETMiami, FL","length":120,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":241,"olType":false},{"type":"text","content":"The live and archived webcasts will be available at https://ir.iovance.com/news-events/events-presentations.","length":113,"tagName":"p"},{"type":"text","content":"About Iovance Biotherapeutics, Inc.","length":40,"tagName":"p"},{"type":"text","content":"Iovance Biotherapeutics, Inc. aims to be the global leader in innovating, developing, and delivering tumor infiltrating lymphocyte (TIL) therapies for patients with cancer. We are pioneering a transformational approach...

More updates from Iovance Biotherapeutics, Inc.